IART

Integra LifeSciences Holdings

IART, USA

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

https://www.integralife.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
IART
stock
IART

Integra Lifesciences Adopts New Severance Program TipRanks

Read more →
IART
stock
IART

Holdings of Integra Lifesciences Holdings Corp (IART) are aligned with the stars setenews.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$15.5

Analyst Picks

Strong Buy

2

Buy

1

Hold

5

Sell

2

Strong Sell

2

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.01

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-0.52 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.15 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

6.40 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

2.51

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 108.37% of the total shares of Integra LifeSciences Holdings

1.

BlackRock Inc

(13.2867%)

since

2025/06/30

2.

Vanguard Group Inc

(9.7269%)

since

2025/06/30

3.

Rubric Capital Management LP

(9.4389%)

since

2025/06/30

4.

iShares Core S&P Small-Cap ETF

(5.1034%)

since

2025/08/31

5.

Morgan Stanley - Brokerage Accounts

(5.0494%)

since

2025/06/30

6.

Fuller & Thaler Asset Management Inc

(4.9961%)

since

2025/06/30

7.

Amvescap Plc.

(4.5401%)

since

2025/06/30

8.

FullerThaler Behavioral Small-Cap Value

(4.4635%)

since

2025/06/30

9.

Undiscovered Managers Behavioral Val L

(4.2733%)

since

2025/07/31

10.

Invesco Small Cap Value A

(4.0186%)

since

2025/07/31

11.

Dimensional Fund Advisors, Inc.

(3.7448%)

since

2025/06/30

12.

State Street Corp

(3.6278%)

since

2025/06/30

13.

Paradigm Capital Management, Inc.

(2.8%)

since

2025/06/30

14.

Vanguard Total Stock Mkt Idx Inv

(2.6327%)

since

2025/07/31

15.

Goldman Sachs Group Inc

(2.2147%)

since

2025/06/30

16.

Geode Capital Management, LLC

(2.1082%)

since

2025/06/30

17.

iShares Russell 2000 ETF

(2.0835%)

since

2025/08/31

18.

Vanguard Small Cap Index

(2.0575%)

since

2025/07/31

19.

Soleus Capital Management, L.P.

(1.7813%)

since

2025/06/30

20.

Wellington Management Company LLP

(1.6991%)

since

2025/06/30

21.

Charles Schwab Investment Management Inc

(1.5672%)

since

2025/06/30

22.

Assenagon Asset Management SA

(1.5328%)

since

2025/06/30

23.

Systematic Financial Management LP

(1.3566%)

since

2025/06/30

24.

Vanguard Small Cap Value Index Inv

(1.3298%)

since

2025/07/31

25.

Neuberger Berman Group LLC

(1.102%)

since

2025/06/30

26.

Millennium Management LLC

(1.0741%)

since

2025/06/30

27.

Deerfield Management Co

(1.0202%)

since

2025/06/30

28.

VOLORIDGE INVESTMENT MANAGEMENT, LLC

(0.9624%)

since

2025/06/30

29.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9281%)

since

2025/07/31

30.

Fidelity Small Cap Index

(0.8644%)

since

2025/06/30

31.

iShares S&P Small-Cap 600 Value ETF

(0.7993%)

since

2025/08/31

32.

Glenmede Small Cap Equity

(0.7929%)

since

2025/06/30

33.

Glenmede Small Cap Equity Adv

(0.7929%)

since

2025/06/30

34.

iShares Russell 2000 Value ETF

(0.7599%)

since

2025/08/31

36.

DFA US Targeted Value I

(0.7152%)

since

2025/07/31

37.

Schwab Fundamental U.S. Small CompanyETF

(0.6812%)

since

2025/08/30

38.

Dimensional US Targeted Value ETF

(0.5695%)

since

2025/08/29

39.

Paradigm Micro-Cap

(0.5647%)

since

2025/08/31

40.

DFA US Small Cap Value I

(0.559%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.8101

Latest Release

Date

2025-09-30

EPS Actual

0.54

EPS Estimate

0.43

EPS Difference

0.11

Surprise Percent

25.5814%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(3.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.